Genova Diagnostics

Asheville, United States Founded: 1986 • Age: 40 yrs Acquired By LLCP
Chronic disease diagnosis through specialized testing is offered.

About Genova Diagnostics

Genova Diagnostics is a Healthcare company based in Asheville (United States) founded in 1986, and was acquired by LLCP in November 2013. It operates as a chronic disease diagnosis through specialized testing is offered. It operates on a Professional Services and Direct-to-Consumer (D2C) model. Its website gdx.net draws about 138 thousand monthly visits. Genova Diagnostics offers products and services including GI Effects Comprehensive Stool Profile, NutrEval, and Endo+. Its focus areas include Diagnostics and Personalized Health Testing. Its legal entity is Genova Diagnostics (GDX). Its competitors include Omniome, Tessera Therapeutics, HitGen, Phase Genomics and Hexagon Bio and 5 more; 8 of its 10 listed competitors have raised funding.

Company details

Personalized health assessments are provided by Genova Diagnostics through advanced diagnostic testing. Focus is placed on gut health, nutrition, hormonal balance, immune function, and genomics. Comprehensive panels and individual add-ons are designed to identify root causes of chronic health issues. Clinical data is utilized to offer actionable recommendations tailored to unique biological profiles. Services cater to both healthcare professionals and individuals seeking wellness solutions. Testing can often be completed from home, with results accessible online for review with physicians.

  • Headquarters Asheville, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website gdx.net
  • Social LinkedIn X Facebook Instagram YouTube
  • Acquired by LLCP (Nov 2013)
  • Legal Name Genova Diagnostics (Gdx)
Key Metrics

Products & Services of Genova Diagnostics

Genova Diagnostics offers a comprehensive portfolio of products and services, including GI Effects Comprehensive Stool Profile, NutrEval, and Endo+.

GI Effects Comprehensive Stool Profile
Gut Health

Insight into digestive function and intestinal microbiome is provided.

NutrEval
Nutrition

Nutritional needs and toxic exposures are assessed accurately.

Endo+
Hormonal Health

Hormonal balance and related issues are evaluated thoroughly.

Apps and channels of Genova Diagnostics

its YouTube channel Genova Diagnostics has 9.09K subscribers and 30 videos.

Genova Diagnostics
YouTube 9.09K subscribers 30 videos Howto & Style
Open channel

Videos from Genova Diagnostics

The most watched videos on Genova Diagnostics's YouTube channel, Genova Diagnostics (9.09K subscribers). Click a video to play it here.

SIBO Breath Test Collection
21.1K views
Genova Diagnostics GI Effects 1 Day Collection
10.7K views
Interpreting the GI Effects Profile. Overview and Case Study Review.
8K views
Genova Diagnostics GI Effects 3 Day Collection
5.9K views

More on Genova Diagnostics.

Investors in Genova Diagnostics

Genova Diagnostics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Levine Leichtman Capital Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
A middle market private equity firm with structured investment strategies.
1984llcp.comBeverly Hills, United States
Premium access

Investor details for Genova Diagnostics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Genova Diagnostics

33 people are tracked at Genova Diagnostics (14 in leadership, 19 in team).

NameRoleGroup
Earlene Clark
Chief Compliance OfficerLeadership
Patricia Devers
Chief Clinical OfficerLeadership
Ceco Ivanov
Chief Information OfficerLeadership
Todd Alston
Director Of Recruiter And Community EngagementLeadership
Jeffrey Ledford
CEOLeadership
Jeff Ellis
Chief Commerical OfficerLeadership
Craig Thiel
Chief Financial OfficerLeadership
Amy Peacebrewer
Chief Clinical & Scientific OfficerLeadership
Bob David
Lab DirectorLeadership
Teresa McKenzie
Director Of Human ResourcesLeadership
Kim Darr
National Sales DirectorLeadership
Melissa Robinson
Marketing DirectorLeadership
David Barrett
Marketing Creative DirectorLeadership
Michael Chapman Nd
Director Of Product InnovationLeadership
Kurt Jarrett
Software DeveloperTeam
Jamesia Veazey Orelaja M.s, Mcm (ASCP)
Clinical Lab TechnologistTeam
Bob Rountree
Speaker's BureauTeam
Hege Løvereide
Customer Service And Finance AssistantTeam
Amanda Crowder
Laboratory TechnicianTeam
Allie Larkin
Chemical Laboratory Tech IITeam

13 more people are available in the full profile.

Premium access

Complete people profiles for Genova Diagnostics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Genova Diagnostics

2 dated milestones of Genova Diagnostics across 27 years, from founding to its latest funding, stage changes and deals.

  1. Founded Genova Diagnostics is founded.
  2. Exit Acquired by LLCP.

Competitors of Genova Diagnostics

Genova Diagnostics has 10 listed competitors in our database, 8 of them funded. They include Omniome, Tessera Therapeutics, HitGen, Phase Genomics and Hexagon Bio, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
omniome.com2013San Diego, United States$160.23M164
Genome sequencing platform is provided for clinical diagnostics.
tesseratherapeutics.com2017Cambridge, United States$610M149
New genome engineering technology is provided for treating multiple diseases.
hitgen.com2012Lanzhou, China$39.11M–
DNA-encoded libraries are developed for drug discovery applications.
phasegenomics.com2015Seattle, United States$5.75M19
Laboratory and computational services for DNA proximity analysis are provided.
hexagonbio.com2017Menlo Park, United States$205.6M34
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
novogene.com2011Beijing, China$75M141
Genomic services and solutions with NGS expertise are provided.
novellusdx.com2011Jerusalem, Israel$85.5M–
Developer of technology for precision cancer diagnosis and therapies
bgi.com1999Shenzhen, China–25
BGI is engaged in genomics and precision medicine solutions.
genewiz.com1999South Plainfield, United States–452
Genomic services are provided for the life sciences industry.
seqone.com2017Montpellier, France$48.79M–
Bioinformatics tools for genome sequencing data analysis are provided.
Premium access

Detailed competitors of Genova Diagnostics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Genova Diagnostics

The website of Genova Diagnostics (gdx.net) receives about 138.4K visits a month and ranks #247,946 among all websites worldwide, #8,361 in Health.

  • Monthly visits
    138.4K

    ▲ 3.3% vs previous month

  • Unique visitors
    50K

    per month

  • Global rank
    #247,946

    among all websites

  • Category rank
    #8,361

    Health · Health

Similar websites

Websites whose visitors overlap most with Genova Diagnostics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
rupahealth.com
100%
705.4K#83,610View details
abramsroyalpharmacy.com
abramsroyalpharmacy.com
100%
–––
accessmedlab.com
100%
30.7K#756,972View details
bodylogicmd.com
bodylogicmd.com
100%
–#522,415–
orthomolecularproducts.com
orthomolecularproducts.com
100%
–#288,375–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Genova Diagnostics

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

10 companies that operate in the same segment as Genova Diagnostics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.34 BUSD 301.49 M1,372
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M562
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Genova Diagnostics

Premium access

Complete news archive for Genova Diagnostics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Genova Diagnostics

Genova Diagnostics was founded in 1986.

Genova Diagnostics is headquartered in Asheville, United States. It is registered at Asheville, North Carolina, United States.

Personalized health assessments are provided by Genova Diagnostics through advanced diagnostic testing. Focus is placed on gut health, nutrition, hormonal balance, immune function, and genomics. Comprehensive panels and individual add-ons are designed to identify root causes of chronic health issues. Clinical data is utilized to offer actionable recommendations tailored to unique biological profiles. Services cater to both healthcare professionals and individuals seeking wellness solutions. Testing can often be completed from home, with results accessible online for review with physicians.

Genova Diagnostics's top competitors include Tessera Therapeutics, Novogene Corporation and Phase Genomics.

Genova Diagnostics offers GI Effects Comprehensive Stool Profile, NutrEval, and Endo+.

Genova Diagnostics has 1 investor. Key investors include Levine Leichtman Capital Partners.

Genova Diagnostics operates through Genova Diagnostics (Gdx).

Yes. Genova Diagnostics was acquired by LLCP in November 2013.

The website of Genova Diagnostics receives about 138 thousand visits a month and ranks #247,946 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available